BiotechTube
Home/Guardian Therapeutics/Jim Gilbert, MD
JG

Jim Gilbert, MD

CEO, Co-Founder

Guardian Therapeutics

Therapeutic Areas

HematologyGastroenterologyDermatologyOncologyImmunology

Guardian Therapeutics Pipeline

DrugIndicationPhase
BT200 (inferred)Thrombotic/Hematologic Disorder (targets vWF A1 domain)Pre-clinical
ApDC Oncology PlatformOncology (unspecified)Pre-clinical
Gastroenterology ProgramGastrointestinal Disorder (unspecified)Pre-clinical
Dermatology ProgramDermatologic Disorder (unspecified)Pre-clinical

Leadership Team at Guardian Therapeutics

SZ
Shuhao Zhu, PhD
CSO, Co-Founder
View full Guardian Therapeutics profile